Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22192246 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin;   Drug: Metformin XR

Indicates status has not been verified in more than two years